Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | SLIRP | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Slirp (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLIRP mRNA | CTD | PMID:22206623 | SLIRP | Human | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of C14ORF156 mRNA | CTD | PMID:23019147 | SLIRP | Human | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Slirp (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | SLIRP | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Slirp (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLIRP mRNA | CTD | PMID:33387578 | SLIRP | Human | 3',5'-cyclic UMP | affects binding | EXP | | 6480464 | SLIRP protein binds to cyclic 3' and 5'-uridine monophosphate | CTD | PMID:30528433 | SLIRP | Human | 6-propyl-2-thiouracil | increases expression | ISO | Slirp (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of SLIRP mRNA | CTD | PMID:30047161 | SLIRP | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of SLIRP gene | CTD | PMID:27153756 | SLIRP | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of SLIRP mRNA | CTD | PMID:21934132 | SLIRP | Human | amitrole | increases expression | ISO | Slirp (Rattus norvegicus) | 6480464 | Amitrole results in increased expression of SLIRP mRNA | CTD | PMID:30047161 | SLIRP | Human | arsenite(3-) | multiple interactions | EXP | | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to SLIRP mRNA] | CTD | PMID:32406909 | SLIRP | Human | bisphenol A | increases expression | ISO | Slirp (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of SLIRP mRNA | CTD | PMID:25181051 | SLIRP | Human | bisphenol A | increases expression | ISO | Slirp (Mus musculus) | 6480464 | bisphenol A results in increased expression of SLIRP mRNA | CTD | PMID:33221593 | SLIRP | Human | bisphenol A | decreases expression | ISO | Slirp (Mus musculus) | 6480464 | bisphenol A results in decreased expression of SLIRP mRNA | CTD | PMID:30245210 | SLIRP | Human | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of SLIRP mRNA | CTD | PMID:30903817 | SLIRP | Human | carbon nanotube | increases expression | ISO | Slirp (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in increased expression of SLIRP mRNA | CTD | PMID:25554681 | SLIRP | Human | chloropicrin | increases expression | EXP | | 6480464 | chloropicrin results in increased expression of C14ORF156 mRNA | CTD | PMID:26352163 | SLIRP | Human | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of SLIRP mRNA | CTD | PMID:19376846 | SLIRP | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of SLIRP mRNA | CTD | PMID:19549813 | SLIRP | Human | crocidolite asbestos | increases expression | ISO | Slirp (Mus musculus) | 6480464 | Asbestos and Crocidolite results in increased expression of SLIRP mRNA | CTD | PMID:29279043 | SLIRP | Human | epoxiconazole | increases expression | ISO | Slirp (Mus musculus) | 6480464 | epoxiconazole results in increased expression of SLIRP mRNA | CTD | PMID:35436446 | SLIRP | Human | fenthion | increases expression | ISO | Slirp (Mus musculus) | 6480464 | Fenthion results in increased expression of SLIRP mRNA | CTD | PMID:34813904 | SLIRP | Human | fenvalerate | increases expression | ISO | Slirp (Rattus norvegicus) | 6480464 | fenvalerate results in increased expression of SLIRP mRNA | CTD | PMID:30307764 | SLIRP | Human | fipronil | decreases expression | ISO | Slirp (Rattus norvegicus) | 6480464 | fipronil results in decreased expression of SLIRP mRNA | CTD | PMID:23962444 | SLIRP | Human | folic acid | multiple interactions | ISO | Slirp (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLIRP mRNA | CTD | PMID:22206623 | SLIRP | Human | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of SLIRP protein | CTD | PMID:37730182 | SLIRP | Human | gold atom | decreases expression | EXP | | 6480464 | Gold results in decreased expression of C14ORF156 mRNA | CTD | PMID:25523186 | SLIRP | Human | gold(0) | decreases expression | EXP | | 6480464 | Gold results in decreased expression of C14ORF156 mRNA | CTD | PMID:25523186 | SLIRP | Human | hydralazine | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of SLIRP mRNA | CTD | PMID:17183730 | SLIRP | Human | inulin | multiple interactions | ISO | Slirp (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLIRP mRNA | CTD | PMID:36331819 | SLIRP | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of SLIRP protein | CTD | PMID:32959892 | SLIRP | Human | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of SLIRP mRNA | CTD | PMID:28903495 | SLIRP | Human | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of SLIRP mRNA | CTD | PMID:35877022 | SLIRP | Human | methidathion | increases expression | ISO | Slirp (Mus musculus) | 6480464 | methidathion results in increased expression of SLIRP mRNA | CTD | PMID:34813904 | SLIRP | Human | methimazole | increases expression | ISO | Slirp (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of SLIRP mRNA | CTD | PMID:30047161 | SLIRP | Human | oxaliplatin | multiple interactions | ISO | Slirp (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of SLIRP mRNA | CTD | PMID:25729387 | SLIRP | Human | ozone | increases phosphorylation | ISO | Slirp (Rattus norvegicus) | 6480464 | Ozone results in increased phosphorylation of SLIRP protein | CTD | PMID:33146391 | SLIRP | Human | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of SLIRP mRNA | CTD | PMID:35430440 | SLIRP | Human | ozone | multiple interactions | ISO | Slirp (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SLIRP mRNA | CTD | PMID:34911549 | SLIRP | Human | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of SLIRP mRNA | CTD | PMID:25704631 | SLIRP | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Slirp (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLIRP mRNA | CTD | PMID:36331819 | SLIRP | Human | propiconazole | increases expression | ISO | Slirp (Rattus norvegicus) | 6480464 | propiconazole results in increased expression of SLIRP mRNA | CTD | PMID:30047161 | SLIRP | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of C14ORF156 mRNA | CTD | PMID:23557933 | SLIRP | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of SLIRP protein | CTD | PMID:37664457 | SLIRP | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of SLIRP mRNA | CTD | PMID:34032870 | SLIRP | Human | sulfadimethoxine | increases expression | ISO | Slirp (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in increased expression of SLIRP mRNA | CTD | PMID:30047161 | SLIRP | Human | tetrachloromethane | increases expression | ISO | Slirp (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of SLIRP mRNA | CTD | PMID:31919559 | SLIRP | Human | toluene | decreases expression | ISO | Slirp (Rattus norvegicus) | 6480464 | Toluene results in decreased expression of SLIRP mRNA | CTD | PMID:22967744 | SLIRP | Human | topotecan | multiple interactions | ISO | Slirp (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of SLIRP mRNA | CTD | PMID:25729387 | SLIRP | Human | trichloroethene | decreases expression | ISO | Slirp (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of SLIRP mRNA | CTD | PMID:33387578 | SLIRP | Human | tungsten | increases expression | ISO | Slirp (Mus musculus) | 6480464 | Tungsten results in increased expression of SLIRP mRNA | CTD | PMID:30912803 | SLIRP | Human | valproic acid | multiple interactions | EXP | | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of SLIRP mRNA | CTD | PMID:17183730 | SLIRP | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of SLIRP mRNA and Valproic Acid results in increased expression of SLIRP protein | CTD | PMID:29501571 | |